Learn about the latest advances in lung disease treatment from the experts of the Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine, led by Charles A. Powell, MD, the Janice and Coleman Rabin Professor of Medicine. Our lung transplant and lung cancer programs are leading the nation in discoveries of new treatments and development of new procedures, and our integrated sleep center is conducting groundbreaking research through important collaborations with our partners in cardiology, genomics, and clinical immunology. Our physicians offer the latest treatment options for conditions such as asthma, sleep apnea, cystic fibrosis, interstitial lung disease, lung cancer and bronchiectasis, emphysema, chronic pulmonary obstructive disease (COPD), and more. For patients with sarcoidosis, we offer one of the largest programs in the nation, providing the latest treatment options. The Division of Pulmonology, Critical Care and Sleep Medicine at The Mount Sinai Hospital is nationally ranked by U.S. News & World Report® for 2024-25.
Learn about the latest advances in lung disease treatment from the experts of the Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine, led by Charles A. Powell, MD, the Janice and Coleman Rabin Professor of Medicine. Our lung transplant and lung cancer programs are leading the nation in discoveries of new treatments and development of new procedures, and our integrated sleep center is conducting groundbreaking research through important collaborations with our partners in cardiology, genomics, and clinical immunology. Our physicians offer the latest treatment options for conditions such as asthma, sleep apnea, cystic fibrosis, interstitial lung disease, lung cancer and bronchiectasis, emphysema, chronic pulmonary obstructive disease (COPD), and more. For patients with sarcoidosis, we offer one of the largest programs in the nation, providing the latest treatment options. The Division of Pulmonology, Critical Care and Sleep Medicine at The Mount Sinai Hospital is nationally ranked by U.S. News & World Report® for 2024-25.
Mount Sinai researchers are exploring the finding that certain proteins produced by patients with mild to moderate eosinophilic asthma downregulate the angiotensin-converting enzyme 2 receptor that allows SARS-CoV-2 entry to airway cells, ...
Mount Sinai Health System recently opened a comprehensive pulmonary rehabilitation program geared to patients with exercise limitations attributable to the lung or other organs. It offers them 8 to 12 weeks of muscle strengthening, helpful ...
Sleep researchers at Mount Sinai have made a major breakthrough by developing a new model that analyzes sleep study data using generative artificial intelligence. This advance provides a robust profile of patient risk for not just cardiovascular ...
For patients with pleural mesothelioma, having a higher sum of maximum pleural thickness at three specific levels measured in the axial plane predicts worse survival. This finding informs the forthcoming ninth edition of the TNM Staging ...
A pneumatocele that occupied almost the entirety of Baby P’s right lower lung was becoming life-threatening. But with help from the Chronic Lung Care team at Mount Sinai Kravis Children’s Hospital, he is now doing well.
Mount Sinai Health System is taking a systematic approach to addressing incidental lung nodules. It includes using natural language processing to scan all Mount Sinai Morningside and Mount Sinai West chest-related radiological reports ...
The Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine provides state-of-the-art consultation, diagnostic testing, and clinical and multidisciplinary care to patients with simple and complex respiratory ...
Interventional bronchoscopy has long been part of the adult pulmonologist's armamentarium; however, it is rarely used in children for a variety of reasons. But at Mount Sinai Kravis Children’s Hospital, interventional bronchoscopy has ...
The new Mount Sinai Multispecialty Lung Nodules Diagnostic and Treatment Program and an in-depth look at our revitalized bronchiectasis program, which also offers patients a range of medical and surgical options, are among the highlights of this year's report.
Despite advances in lung cancer treatment, the disease remains deadly, with the stage of lung cancer at the time of detection being a major determinant in survival. To improve early diagnosis and treatment, the Mount Sinai – National Jewish ...
Robotic-assisted surgery, early intervention, and a comprehensive patient registry are among the ways in which Mount Sinai’s bronchiectasis program continues to distinguish itself in the diagnosis and treatment of the disease. Launched ...
A Mount Sinai surgeon has developed a unique three-incision robotic surgical technique for conducting minimally invasive first-rib resections that he says is safer, more effective, and easily reproducible.
A new study by researchers at the Icahn School of Medicine at Mount Sinai has unraveled the intricate molecular interplay between systemic processes within the blood and localized processes within the airways of individuals with asthma.
Mount Sinai researchers have developed a novel, automated measure of analyzing sleep studies to determine the severity and risk of mortality in patients with obstructive sleep apnea, a chronic sleep disorder that affects about 30 million ...
The Mount Sinai Respiratory Institutes is offering a 2 day comprehensive course on advanced topics in pulmonary medicine, directed toward community pulmonologists, advanced practice NP and PA providers as well primary care physicians.
Influenza infection (flu) is a major cause of death around the world, especially during years of flu pandemics. People who die of the flu often have a secondary lung infection with Staphylococcus aureus (staph) bacteria that starts a few ...
Mount Sinai Health System is using custom 3D-printed stents to open the trachea and main bronchi of patients with complex airway anatomy. Over time, an interventional pulmonologist believes, they could replace standard stenting for benign ...
A new Mount Sinai research program aims to map the developing pediatric airway from minimally invasive respiratory samples obtained during flexible bronchoscopy, with the goal of advancing cystic fibrosis therapeutics and enabling the ...
Mount Sinai’s Scott Scheinin, MD, and Harish Seethamraju, MD, are establishing the End-Stage Lung Disease and Transplant Program as a leader in treating complex cases.
Mount Sinai has launched a novel technology-driven teaching scholars curriculum that uses a blended learning model to prepare subspecialty pulmonary and critical care fellows for careers as clinician-educators.
Mount Sinai is undertaking several initiatives to better understand the factors that contribute to severe asthma and identify different subtypes of the disease. The work is intended to bring a precision medicine approach to asthma.
Mount Sinai's medical intensive care unit is adjusting to the "new normal" post-pandemic by ensuring that its teams have the tools to manage future crises.
Mount Sinai's exercise physiology program, which went dormant during the COVID-19 pandemic, has been revitalized with a new leader, sleek state-of-the-art hardware, software upgrades, and more.
The Mount Sinai – National Jewish Health Respiratory Institute’s Pleural Service, launched in 2020, has used pleuroscopy to dramatically increase its reach and the number and acuity of patients it can serve.
A Mount Sinai physician has developed an algorithm that uses a range of electronic medical record data to identify patients who are ready to be liberated from ventilation.
A first-of-its-kind study led by a Mount Sinai researcher suggests that even a brief withdrawal of continuous positive airway pressure therapy for sleep apnea might increase one’s risk of developing Alzheimer’s disease.
This study provides one of the most comprehensive analyses of interstitial lung disease diagnosis and treatment in patients who received an antibody drug conjugate known as T-DXd, from a class of drugs designed as a targeted therapy for treating cancers.
Mount Sinai Health System, Jefferson Health, and National Jewish Health have begun working together to advance understanding, diagnosis, and treatment of a range of pulmonary diseases, some of which have traditionally been orphan diseases.
The Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine, like the entire Mount Sinai Health System, is making concerted efforts to become an anti-racist institution.
The multidisciplinary Chronic Lung Care Program at Mount Sinai Kravis Children’s Hospital was established to help care for infants in the NICU with evolving and established chronic respiratory failure.
Gene signatures derived from lung carcinoma could potentially predict outcomes among individuals with small lung cancers detected by chest CT imaging, when those tumors cannot be distinguished visually as aggressive or indolent.
Fewer than 10 percent of potentially eligible patients undergo lung cancer screening, resulting in unnecessary illness and death. The new Chief of Pulmonary, Critical Care and Sleep Medicine at Mount Sinai Morningside wants to change that.
Mount Sinai will serve as a hub site for two cohort studies as part of the NIH Researching COVID to Enhance Recovery (RECOVER) Initiative, which will assess the post-acute sequelae of SARS-CoV-2 infection (PASC).
